CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C19204 | BRD-K52657580 | BRD-K52657580 | -- | -- | -- | Details |
C19205 | BRD-K52660225 | BRD-K52660225 | -- | -- | -- | Details |
C19206 | BRD-K52662033 | lidocaine | SCN5A; SCN9A; SCN10A | Histamine receptor agonist | -- | Details |
C19207 | BRD-K52662613 | BRD-K52662613 | -- | -- | -- | Details |
C19208 | BRD-K52665916 | BRD-K52665916 | -- | -- | -- | Details |
C19209 | BRD-K52669647 | BRD-K52669647 | -- | -- | -- | Details |
C19210 | BRD-K52675185 | BRD-K52675185 | -- | -- | -- | Details |
C19211 | BRD-K52678950 | BRD-K52678950 | -- | -- | -- | Details |
C19212 | BRD-K52682771 | BRD-K52682771 | -- | -- | -- | Details |
C19213 | BRD-K52685199 | BRD-K52685199 | -- | -- | -- | Details |
C19214 | BRD-K52688277 | BRD-K52688277 | -- | -- | -- | Details |
C19215 | BRD-K52689785 | BRD-K52689785 | -- | -- | -- | Details |
C19216 | BRD-K52695588 | BRD-K52695588 | -- | -- | -- | Details |
C19217 | BRD-K52696183 | desmethylclomipramine | -- | -- | -- | Details |
C19218 | BRD-K52713598 | BRD-K52713598 | -- | -- | -- | Details |
C19219 | BRD-K52718919 | BRD-K52718919 | -- | -- | -- | Details |
C19220 | BRD-K52719892 | BRD-K52719892 | -- | -- | -- | Details |
C19221 | BRD-K52721289 | XMD-1527 | -- | -- | -- | Details |
C19222 | BRD-K52721673 | BRD-K52721673 | -- | -- | -- | Details |
C19223 | BRD-K52721684 | PCO-400 | KCNJ8 | Potassium channel activator | -- | Details |
C19224 | BRD-K52721778 | BRD-K52721778 | -- | -- | -- | Details |
C19225 | BRD-K52725924 | BRD-K52725924 | -- | -- | -- | Details |
C19226 | BRD-K52726129 | SA-89705 | -- | -- | -- | Details |
C19227 | BRD-K52731672 | BRD-K52731672 | -- | -- | -- | Details |
C19228 | BRD-K52731958 | BRD-K52731958 | -- | -- | -- | Details |
C19229 | BRD-K52735702 | cefdinir | -- | -- | -- | Details |
C19230 | BRD-K52735829 | BRD-K52735829 | -- | -- | -- | Details |
C19231 | BRD-K52751261 | TAK-715 | MAPK14 | P38 MAPK inhibitor | -- | Details |
C19232 | BRD-K52756523 | dirithromycin | -- | -- | -- | Details |
C19233 | BRD-K52758732 | BRD-K52758732 | -- | -- | -- | Details |
C19234 | BRD-K52764062 | BRD-K52764062 | -- | -- | -- | Details |
C19235 | BRD-K52780420 | BRD-K52780420 | -- | -- | -- | Details |
C19236 | BRD-K52785744 | BRD-K52785744 | -- | -- | -- | Details |
C19237 | BRD-K52796804 | BRD-K52796804 | -- | -- | -- | Details |
C19238 | BRD-K52797126 | BRD-K52797126 | -- | -- | -- | Details |
C19239 | BRD-K52800308 | KU-C103658 | -- | -- | -- | Details |
C19240 | BRD-K52801121 | BRD-K52801121 | -- | -- | -- | Details |
C19241 | BRD-K52812196 | BRD-K52812196 | -- | -- | -- | Details |
C19242 | BRD-K52818472 | ivacaftor | CFTR | CFTR channel potentiator | -- | Details |
C19243 | BRD-K52822130 | BRD-K52822130 | -- | -- | -- | Details |
C19244 | BRD-K52827117 | aprepitant | TACR1 | Tachykinin antagonist | -- | Details |
C19245 | BRD-K52827598 | BRD-K52827598 | -- | -- | -- | Details |
C19246 | BRD-K52831370 | BRD-K52831370 | -- | -- | -- | Details |
C19247 | BRD-K52831896 | BRD-K52831896 | -- | -- | -- | Details |
C19248 | BRD-K52833964 | BRD-K52833964 | -- | -- | -- | Details |
C19249 | BRD-K52836380 | AZD-7545 | -- | -- | -- | Details |
C19250 | BRD-K52838656 | BRD-K52838656 | -- | -- | -- | Details |
C19251 | BRD-K52838863 | BRD-K52838863 | -- | -- | -- | Details |
C19252 | BRD-K52842821 | BRD-K52842821 | -- | -- | -- | Details |
C19253 | BRD-K52846581 | BRD-K52846581 | -- | -- | -- | Details |
C19254 | BRD-K52850071 | WHI-P154 | EGFR; JAK3 | JAK inhibitor | -- | Details |
C19255 | BRD-K52854560 | BRD-K52854560 | -- | -- | -- | Details |
C19256 | BRD-K52856667 | BRD-K52856667 | -- | -- | -- | Details |
C19257 | BRD-K52859120 | BRD-K52859120 | -- | -- | -- | Details |
C19258 | BRD-K52862624 | BRD-K52862624 | -- | -- | -- | Details |
C19259 | BRD-K52863921 | BRD-K52863921 | -- | -- | -- | Details |
C19260 | BRD-K52868251 | BRD-K52868251 | -- | -- | -- | Details |
C19261 | BRD-K52870470 | BRD-K52870470 | -- | -- | -- | Details |
C19262 | BRD-K52872067 | BRD-K52872067 | -- | -- | -- | Details |
C19263 | BRD-K52874783 | BRD-K52874783 | -- | -- | -- | Details |
C19264 | BRD-K52876244 | BRD-K52876244 | -- | -- | -- | Details |
C19265 | BRD-K52880714 | BRD-K52880714 | -- | -- | -- | Details |
C19266 | BRD-K52881132 | BRD-K52881132 | -- | -- | -- | Details |
C19267 | BRD-K52882725 | BRD-K52882725 | -- | -- | -- | Details |
C19268 | BRD-K52887203 | BRD-K52887203 | -- | -- | -- | Details |
C19269 | BRD-K52898544 | BRD-K52898544 | -- | -- | -- | Details |
C19270 | BRD-K52904470 | BRD-K52904470 | -- | -- | -- | Details |
C19271 | BRD-K52904986 | BRD-K52904986 | -- | -- | -- | Details |
C19272 | BRD-K52908798 | BRD-K52908798 | -- | -- | -- | Details |
C19273 | BRD-K52911425 | GDC-0941 | PIK3CG | PI3K inhibitor | -- | Details |
C19274 | BRD-K52913754 | BRD-K52913754 | -- | -- | -- | Details |
C19275 | BRD-K52914297 | BRD-K52914297 | -- | -- | -- | Details |
C19276 | BRD-K52914903 | BRD-K52914903 | -- | -- | -- | Details |
C19277 | BRD-K52918979 | BRD-K52918979 | -- | -- | -- | Details |
C19278 | BRD-K52921974 | BRD-K52921974 | -- | -- | -- | Details |
C19279 | BRD-K52924481 | BRD-K52924481 | -- | -- | -- | Details |
C19280 | BRD-K52929685 | BRD-K52929685 | -- | -- | -- | Details |
C19281 | BRD-K52930707 | rescinnamine | ACE | Angiotensin converting enzyme inhibitor | -- | Details |
C19282 | BRD-K52932858 | BRD-K52932858 | -- | -- | -- | Details |
C19283 | BRD-K52938793 | BRD-K52938793 | -- | -- | -- | Details |
C19284 | BRD-K52947657 | BRD-K52947657 | -- | -- | -- | Details |
C19285 | BRD-K52954098 | BRD-K52954098 | -- | -- | -- | Details |
C19286 | BRD-K52955163 | BRD-K52955163 | -- | -- | -- | Details |
C19287 | BRD-K52956006 | BRD-K52956006 | -- | -- | -- | Details |
C19288 | BRD-K52959179 | BRD-K52959179 | -- | -- | -- | Details |
C19289 | BRD-K52959329 | mitiglinide | ABCC8 | Insulin secretagogue | -- | Details |
C19290 | BRD-K52960356 | acetohexamide | -- | -- | -- | Details |
C19291 | BRD-K52964358 | benzene | -- | -- | -- | Details |
C19292 | BRD-K52971351 | BRD-K52971351 | -- | -- | -- | Details |
C19293 | BRD-K52971552 | BRD-K52971552 | -- | -- | -- | Details |
C19294 | BRD-K52973286 | BRD-K52973286 | -- | -- | -- | Details |
C19295 | BRD-K52973836 | ficz | -- | -- | -- | Details |
C19296 | BRD-K52977489 | BRD-K52977489 | -- | -- | -- | Details |
C19297 | BRD-K52978625 | BRD-K52978625 | -- | -- | -- | Details |
C19298 | BRD-K52981369 | BRD-K52981369 | -- | -- | -- | Details |
C19299 | BRD-K52989797 | clomipramine | SLC6A4; SLC6A2 | SERT inhibitor | -- | Details |
C19300 | BRD-K52989901 | BRD-K52989901 | -- | -- | -- | Details |
C19301 | BRD-K53011428 | BRD-K53011428 | -- | -- | -- | Details |
C19302 | BRD-K53022123 | BRD-K53022123 | -- | -- | -- | Details |
C19303 | BRD-K53026281 | BRD-K53026281 | -- | -- | -- | Details |